Vascular NAD(P)H oxidase as a novel therapeutic target in vascular disease

Drug News and Perspectives

Volumn 17, Issue 7, 2004, Pages 429-434

  Brosnan, Julia ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6,8 DIALLYL 5,7 DIHYDROXY (2 ALLYL 3 HYDROXY 4 METHOXYPHENYL) 1H BENZO[B]PYRAN 4 ONE; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; APOCYNIN; ASCORBIC ACID; BENZOPYRAN DERIVATIVE; CHIMERIC PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENYLIODONIUM SALT; GLYCOPROTEIN GP 91; GLYCOPROTEIN GP 91DS TAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PROTEIN KINASE B; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S 17834; STATINE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG TARGETING; ENZYME ACTIVATION; GENE ACTIVATION; GENE THERAPY; HIGH RISK POPULATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIOXIDANTS; BLOOD VESSELS; ENZYME INHIBITORS; HUMANS; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATIVE STRESS; SUPEROXIDES; VASCULAR DISEASES;

EID: 6344251645     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.7.863701     Document Type: Review

References (33)

1. Cai, H. and Harrison, D.G. Endothelial dysfunction in cardiovascular diseases-The role of oxidant stress. Circ Res 2000, 87: 840-4.
2. Berry, C., Brosnan, M.J., Fennell, J., Hamilton, C.A. and Dominiczak, A.F. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 2001, 10: 247-55.
3. Jiang, Z.W., Akey, J.M., Shi, J.X. et al. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 2001, 109: 95-8.
4. Zafari, A.M., Davidoff, M.N., Austin, H. et al. The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 2002, 4: 675-80.
5. Witztum, J.L. and Steinberg, D. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc Medcine 2001, 11: 93-102.
6. Barry-Lane, P.A., Patterson, C., Van der Merwe, M. et al. p47phox is required for atherosclerotic lesion progression in ApoE mice. J Clin Invest 2001, 108: 1513-22.
7. Hsich, E., Segal, B.H., Pagano, P.J. et al. Vascular effects following homozygous disruption of p47(phox)-An essential component of NADPH oxidase. Circulation 2000, 101: 1234-6.
8. Lavigne, M.C., Malech, H.L., Holland, S.M. and Leto, T.L. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001, 104: 79-84.
9. Landmesser, U., Cai, H., Dikalov, S. et al. Role of p47 in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40: 511-5.
10. Alexander, M.Y., Brosnan, M.J., Hamilton, C.A. et al. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn Superoxide dismutase restores nitric oxide availability in the SHRSP. Cardiovasc Res 2000, 47: 609-17.
11. Alexander, M.Y., Brosnan, M.J., Hamilton, C.A. et al. Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model. Cardiovas Res 1999, 43: 798-807.
12. Fennell, J.P., Brosnan, M.J., Frater, A.J. et al. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 2002, 9: 110-7.
13. Lund, D.D., Faraci, F.M., Miller, F.J. and Heistad, D.D. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 2000, 101: 1027-33.
14. Berry, C., Hamilton, C.A., Brosnan, J. et al. Investigation into the sources of superoxide in human blood vessels-Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000, 101: 2206-12.
15. Griendling, K.K., Sorescu, D. and Ushio-Fukai, M. NAD(P)H oxidase-Role in cardiovascular biology and disease. Circ Res 2000, 86: 494-501.
16. Lassegue, B., Sorescu, D., Szocs, K. et al. Novel gp91(phox) homologues in vascular smooth muscle cells-NoxI mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001, 88: 888-94.
17. Lassegue, B., Sorescu, D., Chung, A.B. et al. P65-mox, a novel gp91-phox analogue, participates in superoxide generation and cellular proliferation in vascular smooth muscle. Circulation 1999, 100: 224.
18. Sorescu, D., Weiss, D., Lassegue, B. et al. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 2002, 105: 1429-35.
19. Cai, H., Griendling, K.K. and Harrison, D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003, 24: 471-8.
20. Touyz, R.M., He, G., Wu, X.H., Park, J.B., El Mabrouk, M. and Schiffrin, E.L. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 2001, 38: 56-64.
21. Viedt, C., Soto, U., Krieger-Brauer, H.I. et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II-Involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000, 20: 940-8.
22. Touyz, R.M., Cruzado, M., Tabet, F., Yao, G.Y., Salomon, S. and Schiffrin, E.L. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: Role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 2003, 81: 159-67.
23. Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D. and Alexander, R.W. Angiotensin-II stimulates NADH and NADPH oxidase activity in cultured vascular smooth-muscle cells. Circ Res 1994, 74: 1141-8.
24. Touyz, R.M., Yao, G.Y. and Schiffrin, E.L. Upregulation of Src by Ang II induces oxidative stress in vascular smooth muscle cells from hypertensive patients. Hypertension 2002, 40: 21.
25. Hamilton, C.A., Brosnan, M.J., Al Benna, S., Berg, G. and Dominiczak, A.F. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002, 40: 755-62.
26. Kashiwagi, A., Shinozaki, K., Nishio, Y et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol Endocrinol Metab 1999, 277: E976-83.
27. Van den Worm, E., Beukelman, C.J., Van den Berg, A.J.J., Kroes, B.H., Labadie, R.P. and Van Dijk, H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 2001, 433: 225-30.
28. Cayatte, A.J., Rupin, A., Oliver-Krasinski, J. et al. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler Thromb Vasc Biol 2001, 21: 1577-84.
29. Jacobson, G.M., Dourron, H.M., Liu, J.H. et al. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 2003, 92: 637-43.
30. Rey, F.E., Cifuentes, M.E., Kiarash, A., Quinn, M.T. and Pagano, P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O-2(-) and systolic blood pressure in mice. Circ Res 2001, 89: 408-14.
31. Marklund, S.L., Nilsson, P., Israelsson, K., Schampi, I., Peltonen, M. and Asplund, K. Two variants of extracellular-superoxide dismutase: Relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997, 242: 5-14.
32. Hingorani, A.D., Liang, C.F., Fatibene, J. et al. A common variant of the endothelial nitric oxide synthase (Glu(298)→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100: 1515-20.
33. Lembo, G., De Luca, N., Battagli, C. et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001, 32: 735-40.